Roche cancer programs angle for a starring role at ASCO
Roche cancer programs angle for a starring role at ASCO Fierce Biotech
View ArticleRoche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Coming
Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Coming Bloomberg
View Article5 Biotechs With Upcoming Clinical Trial Results
5 Biotechs With Upcoming Clinical Trial Results Motley Fool
View ArticleMelanoma Set to Be a Hot Topic at ASCO
Melanoma Set to Be a Hot Topic at ASCO WSJ Online
View ArticleRoche preps vismodegib app after Ph2 skin cancer success
Roche preps vismodegib app after Ph2 skin cancer success Fierce Biotech
View ArticleMela Science's Skin Cancer Detector Approved in EU
Mela Science's Skin Cancer Detector Approved in EU Fox News
View ArticleRoche Seeks FDA Approval for Skin Cancer Drug
Roche Seeks FDA Approval for Skin Cancer Drug Bloomberg
View ArticleRoche’s Vismodegib Meets Main Goal of Advanced Skin-Cancer Study
Roche’s Vismodegib Meets Main Goal of Advanced Skin-Cancer Study Bloomberg
View ArticleBristol-Myers Skin-Cancer Drug Yervoy Rejected by U.K. Health Cost Agency
Bristol-Myers Skin-Cancer Drug Yervoy Rejected by U.K. Health Cost Agency Bloomberg
View ArticleFDA gives priority to Roche skin cancer drug vismodegib
FDA gives priority to Roche skin cancer drug vismodegib Pharma Times, UK
View ArticleChronic Bowel Disease Drugs Linked to Skin Cancer Risk
Chronic Bowel Disease Drugs Linked to Skin Cancer Risk Yahoo/Health Day
View ArticleRoche’s Zelboraf for Melanoma Spurs Other Skin Cancer’s Growth, Study Says
Roche’s Zelboraf for Melanoma Spurs Other Skin Cancer’s Growth, Study Says Bloomberg
View ArticleFDA Approves Roche, Curis Skin-Cancer Drug
FDA Approves Roche, Curis Skin-Cancer Drug TheStreet.com
View ArticleHow OncoSec Opens Up Skin Cancer Cells To Drugs
How OncoSec Opens Up Skin Cancer Cells To Drugs Seeking Alpha
View ArticleBristol-Myers Immune Drug Puts Deadly Cancers on Hold in Study
Bristol-Myers Immune Drug Puts Deadly Cancers on Hold in Study Bloomberg
View ArticleBristol Immune Drug Success In Cancer May Spur Industry Race
Bristol Immune Drug Success In Cancer May Spur Industry Race Bloomberg
View ArticleRoche Drug Reduces Skin Growths In Gene-Mutation Patients
Roche Drug Reduces Skin Growths In Gene-Mutation Patients Bloomberg
View ArticleRoche’s Zelboraf Fails To Win U.K. Drug-Cost Agency Backing
Roche’s Zelboraf Fails To Win U.K. Drug-Cost Agency Backing Bloomberg
View ArticleImmunoGen, Inc. Announces SAR566658 Clinical Findings Reported at...
ImmunoGen, Inc. Announces SAR566658 Clinical Findings Reported at AACR-NCI-EORTC Conference Yahoo/BusinessWire
View Article
